This extravascular hemolysis can contribute to suboptimal hemoglobin levels and a continued need for transfusions in patients with PNH who receive C5 inhibitors [3,5,15,16,17]. This evidence concerns the gene C5 and paroxysmal nocturnal hemoglobinuria.